Literature DB >> 7636251

Differences in the shedding of soluble TNF receptors between endotoxin-sensitive and endotoxin-resistant mice in response to lipopolysaccharide or live bacterial challenge.

A Carpenter1, T J Evans, W A Buurman, M H Bemelmans, D Moyes, J Cohen.   

Abstract

TNF-alpha plays a pivotal role in the pathogenesis of septic shock. It exerts its effects by binding two cell surface receptors, designated TNF-R I and II, also referred to as the p55 and p75 receptors, respectively. TNF-Rs are transmembrane proteins, which on cleavage of their extracellular domains, result in the release of soluble fragments (sTNF-R). sTNF-R levels increase markedly during infection, and may serve to modulate TNF-alpha bioactivity. The mechanisms regulating this process are uncertain. To investigate this, we measured sTNF-R release in endotoxin-sensitive C3H/HeN and endotoxin-resistant C3H/HeJ mice given LPS or live Gram-negative bacteria. In C3H/HeN mice, there was a rapid early response during the first 4 h, and a second peak at 8 h, particularly noticeable in the case of the p75 receptor. Prior administration of neutralizing Abs to TNF-alpha or IFN-gamma had no effect on receptor shedding. Surprisingly, C3H/HeJ mice also responded to both bacterial challenge and to LPS by shedding sTNF-R; the magnitude and duration of the early response was not substantially different from C3H/HeN mice, although the second peak was absent. Peritoneal macrophages from C3H/HeN mice responded promptly (5 h) when stimulated with LPS in vitro, and by 22 h levels had increased five- to 10-fold. In contrast, cells from C3H/HeJ mice demonstrated only a very modest response at 22 h following maximal stimulation. The data suggest that there may be at least two separately regulated pathways that control sTNF-R shedding in these mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636251

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice.

Authors:  B Nowicki; J Singhal; L Fang; S Nowicki; C Yallampalli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Sources of alveolar soluble TNF receptors during acute lung injury of different etiologies.

Authors:  Anthony D Dorr; Michael R Wilson; Kenji Wakabayashi; Alicia C Waite; Brijesh V Patel; Nico van Rooijen; Kieran P O'Dea; Masao Takata
Journal:  J Appl Physiol (1985)       Date:  2011-04-21

3.  Soluble tumour necrosis factor (TNF)-receptor levels in serum as markers of anti-viral host reactivity.

Authors:  C Bartholdy; A Nansen; O Marker; A R Thomsen
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

4.  Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1.

Authors:  Manjula Pandey; Gurol Tuncman; Gökhan S Hotamisligil; Fahumiya Samad
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

5.  Lipoprotein release by bacteria: potential factor in bacterial pathogenesis.

Authors:  H Zhang; D W Niesel; J W Peterson; G R Klimpel
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

6.  Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity.

Authors:  Xiangdong Wang; Jing Jiang; Jason Warram; Gerhard Baumann; Yujun Gan; Ram K Menon; Lee A Denson; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2008-03-06

7.  Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis.

Authors:  Jeneen Panezai; Ambereen Ghaffar; Mohammad Altamash; Per-Erik Engström; Anders Larsson
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

Review 8.  Lead (Pb) Exposure Enhances Expression of Factors Associated with Inflammation.

Authors:  Emilia Metryka; Karina Chibowska; Izabela Gutowska; Anna Falkowska; Patrycja Kupnicka; Katarzyna Barczak; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2018-06-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.